High PSALow volume diseaseRarely, patients with prostate cancer (PC) present with Prostate-Specific Antigen (PSA) scores >20ng/mL but otherwise very low-risk disease. Oncologists debate whether malignancies in these patients behave more comparably to low-risk or high-risk disease. Our objective ...
New research shows that prostate specific antigen (PSA), a commonly used serum marker of prostate cancer, inhibits the formation of new blood vessels and consequently slows the progression of the disease (Journal of the National Cancer Institute 1999;91:1635-40).The finding may explain the ...
Prostate-specific antigen (PSA) is the tumor marker most widely used in conjunction with digital rectal examination (DRE) for the early detection of prostate cancer (PCa). Due to its limitations, especially the high rate of false positive (FP) results, PSA screening of transplant candidates is...
The median age of study participants was 64 (age range 48–74). About half (47%) had a PSA greater than 10 ng/mL at diagnosis, which is abnormally high, and 50% had Gleason grade group 5 at biopsy, meaning they had highly aggressive disease. Patients were enrolled from February 2017 ...
Lung volume, airway resistance, and compliance have been measured in 19 infants, 18 of whom suffered from the respiratory distress syndrome (RDS) at birth, while the remaining infant was ventilated for persistent apnea and a pneumothorax. Prior to discharge from the neonatal unit, and after recov...
Background Prostate cancer (PCa) is the most common male cancer in Europe and the US. The early diagnosis relies on prostate specific antigen (PSA) serum test, even if it showed clear limits. Among the new tests currently under study, one of the most promising is the prostate cancer gene...
Prostate cancer care in the Middle East is highly variable and access to specialist multidisciplinary management is limited. Academic tertiary referral cen
New data support the use of laparoscopic radical prostatectomy in men with high-risk prostate cancer, demonstrating good outcomes in terms of disease control, continence and erectile function. 1,975 men with high-risk prostate cancer (PSA ≥20 ng/ml, Gleason ≥8 on biopsy or cT stage ≥2) ...
监测与治疗后psa的前列腺癌是一种临床实践的主体,虽然临床实用程序的psa是可变的,取决于疾病的阶段的indi-vidual病人。 翻译结果5复制译文编辑译文朗读译文返回顶部 相关内容 a谢谢你传授给我们知识 Thank you for your transfer to our knowledge;[translate] ...
Diagram of Study Cohort View LargeDownload M1 indicates bone metastases; NCCN, National Comprehensive Cancer Network; PSA, prostate-specific antigen. Figure 2. Overall Survival of Patients Treated at High vs Low Average Cumulative Facility Radiation Volume Centers View LargeDownload Unadjusted (A) and ...